Episona, Inc.

About:

Episona is an epigenetics data company focused on improving healthcare outcomes.

Website: https://episona.com

Twitter/X: episona

Top Investors: Pasadena Angels

Description:

Episona's first product, Seed, is an epigenetic test for male infertility focused on decreasing cost and time to pregnancy for those seeking fertility care. Clinically, Seed can identify 1) hidden male factor in cases of unexplained infertility and 2) epigenetic patterns that strongly associate with poor embryogenesis. Episona is led by an experienced team of medical doctors and scientists, with world-class expertise in both epigenetics and human reproductive health. The company began operations in 2013 and is headquartered in Pasadena, CA. For more information, visit https://episona.com.

Total Funding Amount:

$4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Pasadena, California, United States

Founded Date:

2013-08-01

Contact Email:

info(AT)episona.com

Founders:

Alan Horsager, Doug Carrell

Number of Employees:

11-50

Last Funding Date:

2017-06-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai